Can a patient take metoprolol succinate (Extended Release) 100mg twice a day?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Metoprolol Succinate Extended-Release Should NOT Be Dosed Twice Daily

Metoprolol succinate extended-release (ER) is specifically formulated for once-daily administration only, and prescribing 100mg twice daily represents incorrect dosing that deviates from evidence-based practice and FDA-approved labeling. 1, 2, 3

Critical Formulation Distinction

Only metoprolol succinate extended-release has proven mortality reduction in heart failure, and this benefit was achieved with once-daily dosing at a target of 200mg daily—not twice-daily administration. 1, 2

  • The extended-release formulation delivers metoprolol at a near-constant rate over approximately 20 hours, producing even plasma concentrations over 24 hours without marked peaks and troughs. 4, 5
  • This controlled-release design provides consistent beta-1 blockade throughout the entire 24-hour dosing interval with once-daily administration. 4, 5
  • The MERIT-HF trial, which demonstrated a 34% reduction in all-cause mortality, used metoprolol succinate ER dosed once daily at a target of 200mg. 1, 5

Why Twice-Daily Dosing Is Inappropriate

The American College of Cardiology and American Heart Association guidelines specifically warn that dosing metoprolol succinate twice daily is inappropriate and deviates from evidence-based practice. 1

  • Metoprolol tartrate (immediate-release) requires twice-daily dosing due to its shorter half-life, but this formulation has NOT demonstrated mortality reduction in heart failure. 1, 2
  • The extended-release pellet system in metoprolol succinate ER is engineered to release drug over 20 hours, making twice-daily dosing pharmacologically unnecessary and potentially leading to excessive drug exposure. 4, 6
  • Prescribing 100mg twice daily (200mg total daily) would be the correct total daily dose, but splitting it defeats the purpose of the extended-release formulation. 1, 2

Correct Dosing Protocol

For heart failure with reduced ejection fraction, start metoprolol succinate ER at 12.5-25mg once daily and titrate every 2 weeks to a target of 200mg once daily. 1, 2

  • Titration schedule: 12.5mg → 25mg → 50mg → 100mg → 200mg once daily, doubling the dose every 2 weeks if tolerated. 1, 7
  • If the full target dose cannot be achieved, aim for at least 50% of target (100mg daily minimum) to maintain mortality benefit. 1, 2
  • For hypertension, the usual dose range is 50-400mg once daily (maximum 400mg daily). 2, 7

Common Prescribing Pitfall

Never confuse metoprolol succinate ER with metoprolol tartrate—they are NOT interchangeable and have different dosing frequencies. 1, 2

  • Metoprolol tartrate: 25-100mg twice daily (immediate-release). 1, 7
  • Metoprolol succinate ER: 12.5-200mg once daily (extended-release). 1, 2
  • The FDA label for metoprolol tartrate specifies dosing every 6-12 hours for acute MI, transitioning to twice-daily maintenance dosing—but this applies only to the immediate-release formulation. 3

Bottom Line

If the patient needs 200mg total daily dose of metoprolol succinate ER, prescribe 200mg once daily, not 100mg twice daily. 1, 2 The twice-daily regimen would only be appropriate if switching to metoprolol tartrate immediate-release, which lacks the mortality benefit proven with the extended-release formulation. 1, 2

References

Guideline

Beta Blocker Therapy Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Metoprolol Succinate Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Extended-release metoprolol succinate in chronic heart failure.

The Annals of pharmacotherapy, 2003

Guideline

Metoprolol Treatment Protocol for Hypertension and Heart-Related Conditions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.